Literature DB >> 15763311

3D conformal radiotherapy for gastric cancer--results of a comparative planning study.

Trevor Leong1, David Willis, Daryl Lim Joon, Sara Condron, Andrew Hui, Samuel Y K Ngan.   

Abstract

BACKGROUND AND
PURPOSE: Many radiation oncologists are reluctant to use anteroposterior-posteroanterior (AP-PA) field arrangements when treating gastric cancer with adjuvant postoperative radiotherapy due to concerns about normal tissue toxicity, particularly in relation to the kidneys and spinal cord. In this report, we describe a multiple-field conformal radiotherapy technique, and compare this technique to the more commonly used AP-PA technique that was used in the recently reported Intergroup study (INT0116).
MATERIALS AND METHODS: Fifteen patients with stages II-IV adenocarcinoma of the stomach were treated with adjuvant postoperative chemoradiotherapy using a standardised 3D conformal radiotherapy technique that consisted of a 'split-field', mono-isocentric arrangement employing 6 radiation fields. For each patient, a second radiotherapy treatment plan was generated utilising AP-PA fields. The two techniques were then compared for target volume coverage and dose to normal tissues using dose volume histogram (DVH) analysis.
RESULTS: The conformal technique provides more adequate coverage of the target volume with 99% of the planning target volume (PTV) receiving 95% of the prescribed dose, compared to 93% using AP-PA fields. Comparative DVHs for the right kidney, left kidney and spinal cord demonstrate lower radiation doses using the conformal technique, and although the liver dose is higher, it is still well below liver tolerance.
CONCLUSIONS: 3D conformal radiotherapy produces superior dose distributions and reduced radiation doses to the kidneys and spinal cord compared to AP-PA techniques, with the potential to reduce treatment toxicity.

Entities:  

Mesh:

Year:  2005        PMID: 15763311     DOI: 10.1016/j.radonc.2005.01.006

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  23 in total

1.  Evaluation of the toxicity of the combined treatment of chemoradiotherapy, according to the scheme of Macdonald, after radical surgery in patients diagnosed of gastric cancer.

Authors:  Vicente Tormo Ferrero; Francisco José Andreu Martínez; Rafael Cardenal Macía; Almudena Pomares Arias
Journal:  Clin Transl Oncol       Date:  2006-08       Impact factor: 3.405

2.  Influence of interfraction motion on margins for radiotherapy of gastric cancer.

Authors:  A Namysł-Kaletka; J Wydmanski; A Tukiendorf; D Bodusz; W Leszczynski; R Kawczynski; K Grabinska; P Polanowski
Journal:  Br J Radiol       Date:  2015-02-10       Impact factor: 3.039

Review 3.  Chemoradiation for gastric cancer: controversies, updates and novel techniques.

Authors:  M Fan; W Hu; Z Zhang
Journal:  Br J Radiol       Date:  2015-04-01       Impact factor: 3.039

4.  Protection of organs at risk during neoadjuvant chemoradiotherapy for gastric cancer based on a comparison between conformal and intensity-modulated radiation therapy.

Authors:  Leszek Hawrylewicz; Wojciech Leszczyński; Agnieszka Namysł-Kaletka; Iwona Bronclik; Jerzy Wydmański
Journal:  Oncol Lett       Date:  2016-05-26       Impact factor: 2.967

5.  Can we obtain planning goals for conformal techniques in neoadjuvant and adjuvant radiochemotherapy for gastric cancer patients?

Authors:  Wojciech Leszczyński; Paweł Polanowski; Paulina Leszczyńska; Leszek Hawrylewicz; Iwona Brąclik; Rafał Kawczyński; Jerzy Wydmański
Journal:  Rep Pract Oncol Radiother       Date:  2016-02-08

6.  Evaluation of internal target volume in patients undergoing image-guided intensity modulated adjuvant radiation for gastric cancers.

Authors:  A Aggarwal; S Chopra; S N Paul; R Engineer; S K Srivastava
Journal:  Br J Radiol       Date:  2013-11-28       Impact factor: 3.039

Review 7.  Current adjuvant treatment modalities for gastric cancer: From history to the future.

Authors:  Leyla Kilic; Cetin Ordu; Ibrahim Yildiz; Fatma Sen; Serkan Keskin; Rumeysa Ciftci; Kezban Nur Pilanci
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

8.  Phase I study of postoperative radiotherapy combined with capecitabine for gastric cancer.

Authors:  Xin Wang; Jing Jin; Ye-Xiong Li; Hua Ren; Hui Fang; Shu-Lian Wang; Yue-Ping Liu; Wei-Hu Wang; Zi-Hao Yu; Yong-Wen Song; Xin-Fan Liu
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

9.  Quality Research in Radiation Oncology analysis of clinical performance measures in the management of gastric cancer.

Authors:  Karyn A Goodman; Najma Khalid; Lisa A Kachnic; Bruce D Minsky; Cheryl Crozier; Jean B Owen; Phillip M Devlin; Charles R Thomas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-10-03       Impact factor: 7.038

10.  Usefulness of chemoradiotherapy for inoperable gastric cancer.

Authors:  T Taki; Y Hoya; A Watanabe; T Nakayoshi; T Okamoto; H Sekine; N Mitsumori; K Yanaga
Journal:  Ann R Coll Surg Engl       Date:  2016-09-23       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.